A preclinical study reveals a potential combination therapy that targets prostate cancers that evade treatment by changing their cellular identity, slowing tumor growth.
Researchers identify new vulnerability in treatment-resistant prostate cancer
A preclinical study reveals a potential combination therapy that targets prostate cancers that evade treatment by changing their cellular identity, slowing tumor growth.
Prostate cancer · Wikimedia — licence per file · rights
Monitoring item. The full text is not distributed. Extract and source below.